Vyxeos and Furosemide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Vyxeos (cytarabine; daunorubicin) and Furosemide (furosemide). Common drug interactions include cardiogenic shock among females and aplastic anaemia among males.

The phase IV clinical study analyzes what interactions people have when they take Vyxeos and Furosemide. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Vyxeos?

Vyxeos has active ingredients of cytarabine; daunorubicin. eHealthMe is studying from 1,217 Vyxeos users. Check the latest studies of Vyxeos.

What is Furosemide?

Furosemide has active ingredients of furosemide. It is often used in fluid retention. eHealthMe is studying from 316,095 Furosemide users. Check the latest studies of Furosemide.

On Jul, 09, 2026

19 people who take Vyxeos and Furosemide together, and have interactions are studied.

Vyxeos and Furosemide drug interactions.

What are the common drug interactions of Vyxeos and Furosemide, by gender? *:

female:

Cardiogenic shock (inadequate circulation of blood)
Cardiomyopathy (weakening of the heart muscle)

male:

Aplastic anaemia (blood disorder in which the body's bone marrow doesn't make enough new blood cells)
Mucosal inflammation (infection of mucous membrane)
Gastrointestinal angiodysplasia (a small vascular malformation of the gut)
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)
Pyrexia (fever)
Tumour lysis syndrome (a group of metabolic complications that can occur after treatment of cancer, these complications are caused by the breakdown products of dying cancer cells)
Weight increased
Pericarditis (inflammation of the pericardium)
Rash

What are the common drug interactions of Vyxeos and Furosemide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Aplastic anaemia (blood disorder in which the body's bone marrow doesn't make enough new blood cells)
Mucosal inflammation (infection of mucous membrane)

10-19:

n/a

20-29:

n/a

30-39:

Pericarditis (inflammation of the pericardium)
Rash

40-49:

n/a

50-59:

Blood phosphorus increased
Lung infiltration (a substance that normally includes fluid, inflammatory exudates or cells that fill a region of lung)
Pyrexia (fever)
Weight increased
Blood creatinine increased

60+:

Cardiogenic shock (inadequate circulation of blood)
Cardiomyopathy (weakening of the heart muscle)
Blast cell count increased
Bone marrow failure
Enterococcal sepsis
Febrile neutropenia (fever with reduced white blood cells)
Gastrointestinal angiodysplasia (a small vascular malformation of the gut)
Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
Tumour lysis syndrome (a group of metabolic complications that can occur after treatment of cancer, these complications are caused by the breakdown products of dying cancer cells)

What are the existing conditions these people have? *

Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 10 people, 52.63%
Bone Marrow Conditioning Regimen: 6 people, 31.58%
Sepsis (a severe blood infection that can lead to organ failure and death): 3 people, 15.79%
Pulmonary Oedema (fluid accumulation in the lungs): 2 people, 10.53%
Diabetes: 2 people, 10.53%
Oedema Peripheral (superficial swelling): 1 person, 5.26%
Gastrointestinal Haemorrhage (bleeding gastrointestinal tract): 1 person, 5.26%
Fluid Overload (too much fluid in the blood): 1 person, 5.26%
Febrile Neutropenia (fever with reduced white blood cells): 1 person, 5.26%
Cytogenetic Abnormality: 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Vyxeos and Furosemide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously